Description
Recombinant monoclonal antibody to HVEM. Manufactured using AbAbтАЩs Recombinant Platform with variable regions (i.e. specificity) from the hybridoma HMHV-1B18. This is a reformatted Fc SilentтДв chimeric antibody made using the variable domain sequences of the original hamster (Armenian) antibody format to improve compatibility with existing reagents, assays, and techniques.
Target
HVEM
Target Alias Names
CD270, TNF Receptor-like 2, ATAR, Herpes virus Entry Mediator A, HVEA, Herpes virus Entry Mediator, LIGHTR, Tumor Necrosis Factor Receptor-Like Gene2, Tumor Necrosis Factor Receptor-Like 2, TR2, Tumor Necrosis Factor Receptor Superfamily Member 14, TNFRSF14, CD40-Like Protein
Isotype/Mimetic
IgG2a
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression